HedgeChatter

  • Home /
  • Tag Archives

PSTI

Pluristem to Present at World Stem Cells Regenerative Medicine Congress 2014 in London

[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, announced today that the Company’s CEO Zami Aberman will participate in the 9th Annual World Stem Cells … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Pluristem to Present at World Stem Cells Regenerative Medicine Congress 2014 in London read more

Pluristem to be Added to New TA Tech-Elite Stock Index in Israel

[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics Inc. today announced that its shares of common stock will be added to a newly created TA Tech-Elite index on the Tel Aviv Stock Exchange. Scheduled for launch on … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click […]

May 7, 2014 Bystocknews , Comments Off on Pluristem to be Added to New TA Tech-Elite Stock Index in Israel read more

Pluristem and the Alliance for Regenerative Medicine Advocate for Industry Advancement in Washington D.C.

[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, announced today that Company executives are actively participating in a series of meetings in Washington … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]

April 22, 2014 Bystocknews , Comments Off on Pluristem and the Alliance for Regenerative Medicine Advocate for Industry Advancement in Washington D.C. read more

Pipeline Progress at Pluristem

moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]

February 24, 2014 Bystocknews , Comments Off on Pipeline Progress at Pluristem read more

Pluristem Submits FDA Orphan Drug Application for Preeclampsia

[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, today announced it is submitting its application to the United Stated Food and Drug Administration … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on Pluristem Submits FDA Orphan Drug Application for Preeclampsia read more